Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2

被引:48
|
作者
Downey, P
Sapirstein, A
O'Leary, E
Sun, TX
Brown, D
Bonventre, JV
机构
[1] Massachusetts Gen Hosp, Med Serv, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Anesthesia Serv, Charlestown, MA 02129 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA
[6] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02129 USA
关键词
mouse; osmolality; kidney concentrating mechanism; prostaglandin; aquaporin; eicosanoid;
D O I
10.1152/ajprenal.2001.280.4.F607
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Eicosanoids regulate various cellular functions that are important in physiological and pathophysiological processes. Arachidonic acid is released from membranes by phospholipase A(2) (PLA(2)) activity. Activated macrophages derived from mice lacking the 85-kDa group IV cytosolic PLA(2) (cPLA(2)) have a markedly reduced release of prostaglandin E-2 and leukotrienes B-4 and C-4. Under basal conditions and after furosemide, urinary prostaglandin E-2 excretion is reduced in cPLA(2)-knockout (cPLA(2)(-/-)) mice. Serum creatinine, Na+, K+, and Ca2+ concentrations, glomerular filtration rate, and fractional excretion of Na+ and K+ are not different in cPLA(2)(-/-) and cPLA(2)(-/-) mice. Maximal urinary concentration is lower in 48-h water-deprived cPLA(2)(-/-) mice compared with cPLA(2)(+/+) animals (1,934 +/- 324 vs. 3,541 +/- 251 mmol/kgH(2)O). Plasma osmolality is higher (337 +/- 5 vs. 319 +/- 3 mmol/kgH(2)O) in cPLA(2)(-/-) mice that lose a greater percentage of their body weight (20 +/- 2 vs. 13 +/- 1%) compared with cPLA(2)(+/+) mice after water deprivation. Vasopressin does not correct the concentrating defect. There is progressive reduction in urinary osmolality with age in cPLA(2)(-/-) mice. Membrane-associated aquaporin-1 (AQP1) expression, identified by immunocytochemical techniques, is reduced markedly in proximal tubules of older cPLA(2)(-/-) animals but is normal in thin descending limbs. However, Western blot analysis of kidney cortical samples revealed an equivalent AQP1 signal intensity in cPLA(2)(+/+) and cPLA(2)(-/-) animals. Young cPLA(2)(-/-) mice have normal proximal tubule AQP1 staining. Collecting duct AQP2, -3, and -4 were normally expressed in the cPLA(2)(-/-) mice. Thus mice lacking cPLA(2) develop an age-related defect in renal concentration that may be related to abnormal trafficking and/or folding of AQP1 in the proximal tubule, implicating cPLA(2) in these processes.
引用
收藏
页码:F607 / F618
页数:12
相关论文
共 50 条
  • [22] Cloning and expression of a group IV cytosolic Ca2+-dependent phospholipase A2 from rat pancreatic islets.: Comparison of the expressed activity with that of an islet group VI cytosolic Ca2+-independent phospholipase A2
    Ma, ZM
    Ramanadham, S
    Hu, ZQ
    Turk, J
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1998, 1391 (03): : 384 - 400
  • [23] Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group v secreted phospholipase A2
    Six, David A.
    Barbayianni, Efrosini
    Loukas, Vassilios
    Constantinou-Kokotou, Violetta
    Hadjipavlou-Litina, Dimitra
    Stephens, Daren
    Wong, Alan C.
    Magrioti, Victoria
    Moutevelis-Minakakis, Panagiota
    Baker, Sharon F.
    Dennis, Edward A.
    Kokotos, George
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 4222 - 4235
  • [24] Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease
    Aukema, HM
    Adolphe, J
    Mishra, S
    Jiang, JY
    Cuozzo, FP
    Ogborn, MR
    FASEB JOURNAL, 2002, 16 (14): : 298 - +
  • [25] Overexpression and regulation of cytosolic phospholipase A2 group IVA in patients with asthma
    Sokolowska, M.
    Stefanska, J.
    Luczak, E.
    Wodz-Naskiewicz, K.
    Cieslak, M.
    Pawliczak, R.
    ALLERGY, 2010, 65 : 2 - 3
  • [26] Group IVC cytosolic phospholipase A2 γ is farnesylated and palmitoylated in mammalian cells
    Tucker, DE
    Stewart, A
    Nallan, L
    Bendale, P
    Ghomashchi, F
    Gelb, MH
    Leslie, CC
    JOURNAL OF LIPID RESEARCH, 2005, 46 (10) : 2122 - 2133
  • [27] Role for cytosolic phospholipase A2α in autoimmune diabetes in nonobese diabetic mice
    Oikawa, Y
    Yamato, E
    Tashiro, F
    Yamamoto, M
    Uozumi, N
    Shimada, A
    Shimizu, T
    Miyazaki, JI
    DIABETES, 2005, 54 : A308 - A308
  • [28] Cytosolic phospholipase A2α-deficient mice are resistant to experimental autoimmune encephalomyelitis
    Marusic, S
    Leach, MW
    Pelker, JW
    Azoitei, ML
    Uozumi, N
    Cui, JQ
    Shen, MWH
    DeClercq, CM
    Miyashiro, JS
    Carito, BA
    Thakker, P
    Simmons, DL
    Leonard, JP
    Shimizu, T
    Clark, JD
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06): : 841 - 851
  • [29] Reduced excitotoxic neuronal degeneration in mice deficient in cytosolic phospholipase A2
    Hewett, SJ
    Silakova, JS
    Bonventre, JV
    Hewett, JA
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 42 - 42
  • [30] Roles for cytosolic phospholipase A2α as revealed by gene-targeted mice
    Uozumi, N
    Shimizu, T
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 59 - 69